-+ 0.00%
-+ 0.00%
-+ 0.00%

Abivax asks shareholders to authorize cancellation of up to 10% of shares via buybacks

PUBT·04/20/2026 21:35:52
Listen to the news
Abivax asks shareholders to authorize cancellation of up to 10% of shares via buybacks
  • Abivax shareholders will vote May 11, 2026 on Resolution 16 to delegate authority to board to cancel shares repurchased under a buyback program, reducing share capital.
  • Mandate would run 18 months from meeting date, with cancellations capped at 10% of share capital per 24-month period.
  • Statutory auditors issued a clean view on causes and terms of proposed capital reduction, supporting the resolution.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.